跳至主要内容
临床试验/ITMCTR2100004852
ITMCTR2100004852招募中1 期

Effects of Qidi Tangshen Formulation in treating DKD patients with albuminuria and its effects on oxidative stress

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
30 至 80(—)
性别
All

入选标准

  • 1. No limit to gender, aged 30 to 80 years;
  • 2. Meet the diagnostic criteria of diabetic nephropathy, meet the diagnostic criteria of stage 1-2 chronic kidney disease;
  • 3. Accorded with the diagnostic standard of deficiency of both qi and yin and blood stasis blocking collaterals in traditional Chinese medicine;
  • 4. Sign the patient's informed consent form.

排除标准

  • 1. Uncontrollable malignant hypertension;
  • 2. Rapid deterioration of renal function recently;
  • 3. Combined with serious primary diseases such as cardiovascular, liver, kidney and hematopoietic system, pregnancy;
  • 4. History of adverse reactions to ARB drugs.

研究者

发起方
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine

相似试验